Newsroom
Newsroom
Industry News
As a part of my series about “Lessons From Inspirational Women in STEM and Tech”, I had the pleasure of interviewing Christina Smolke......
Blog Posts
Antheia is at a critical point in scaling our production technology. Just as we bring together exceptional science and technologies to unleash the power of...
Industry News
Drew Endy is squarely focused on the potential of redesigning organisms for useful purposes. He also acknowledges significant challenges......
Industry News
Zack McGahey was named COO and will be responsible for all operations functions as the company scales and commercializes its first products. Prior to joining...
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Zack McGahey as Chief Operating Officer......
Industry News
Antheia CEO Christina Smolke brews up new pharmaceuticals......
Industry News
Obtaining compounds from nature, such as opioids from poppies or taxol from yew trees, is hard and time-consuming. So researchers, including Stanford's Christina Smolke, PhD,...
Industry News
The objective of this Phase I SBIR project will be to develop engineered yeast strains that produce high levels of noroxymorphone, the direct precursor for...
Industry News
The objectives of this Phase I project will be to develop engineered yeast strains that produce high levels of natural and non-natural noscapinoids secoberberines and...
Industry News
Until now, much of the medicines we use to treat dire illnesses have been derived from plants. But that means we are dependent on natural...
Industry News
Early this year, synthetic biologist Christina Smolke was in a dead-heat race with a handful of other labs to engineer a yeast strain capable of...
Industry News
Over the past several months, scientists from around the world have published bits and pieces of a fascinating feat: In an effort to create pain...